Rockefeller Capital Management’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-500
Closed -$6K 2184
2022
Q4
$6K Hold
500
﹤0.01% 3256
2022
Q3
$6K Hold
500
﹤0.01% 3262
2022
Q2
$6K Hold
500
﹤0.01% 3346
2022
Q1
$6K Hold
500
﹤0.01% 3258
2021
Q4
$7K Hold
500
﹤0.01% 3128
2021
Q3
$6K Hold
500
﹤0.01% 3079
2021
Q2
$7K Hold
500
﹤0.01% 2905
2021
Q1
$5K Buy
+500
New +$4.2K ﹤0.01% 2880

Other funds holding BIOX

Rockefeller Capital Management's BIOX Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Bioceres Crop Solutions (BIOX) in Q1 2023, closing a stake of 500 shares — an estimated $6K sold.

Rockefeller Capital Management first reported a position in BIOX in Q1 2021 and held it in 8 quarters. The position peaked at $7K in Q4 2021. 46 funds tracked by Wall St. Rank hold BIOX as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Bioceres Crop Solutions position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 500 Bioceres Crop Solutions shares in Q1 2023, an estimated $6K.
  • Rockefeller Capital Management first reported a position in Bioceres Crop Solutions in Q1 2021 and held it in 8 quarters.
  • Rockefeller Capital Management's Bioceres Crop Solutions position peaked at $7K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.